T Kanai
Overview
Explore the profile of T Kanai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
347
Citations
2610
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uzawa A, Kanai T, Oda F, Ozawa Y, Yasuda M, Kawaguchi N, et al.
Eur J Neurol
. 2019 Jul;
27(1):175-180.
PMID: 31347231
Background And Purpose: Thymectomy is an effective treatment for myasthenia gravis (MG) with anti-acetylcholine receptor (AChR) antibodies. We rarely encounter patients who develop MG after surgery for thymic tumors. This...
2.
Nishida Y, Takahashi Y, Kanai T, Nose Y, Ishibashi S, Sanjo N, et al.
Eur J Neurol
. 2019 Jul;
27(1):100-104.
PMID: 31309642
Background And Purpose: Tapering immunosuppressants is desirable in patients with well-controlled myasthenia gravis (MG). However, the association between tapering of calcineurin inhibitor dosage and reduction-associated exacerbation is not known. The...
3.
Namkoong H, Asakura T, Ishii M, Yoda S, Masaki K, Sakagami T, et al.
New Microbes New Infect
. 2018 Dec;
27:4-6.
PMID: 30505452
This study describes a patient who experienced hepatobiliary infection associated with neutralizing anti-interferon gamma (IFN-γ) autoantibodies during treatment for disseminated disease. Hepatobiliary infection should be considered in jaundiced patients with...
4.
Nakase H, Motoya S, Matsumoto T, Watanabe K, Hisamatsu T, Yoshimura N, et al.
Aliment Pharmacol Ther
. 2017 Sep;
46(9):873-882.
PMID: 28884856
Background: Significance of monitoring adalimumab trough levels and anti-adalimumab antibodies (AAA) for disease outcome in Crohn's disease (CD) patients remained unclear. Aim: To evaluate the association of adalimumab trough levels...
5.
Lourenco A, Thomas R, Homer M, Bouchard H, Rossomme S, Renaud J, et al.
Phys Med Biol
. 2017 Feb;
62(7):N134-N146.
PMID: 28211796
The aim of this work is to develop and adapt a formalism to determine absorbed dose to water from graphite calorimetry measurements in carbon-ion beams. Fluence correction factors, [Formula: see...
6.
Kanai T, Uzawa A, Kawaguchi N, Himuro K, Oda F, Ozawa Y, et al.
Eur J Neurol
. 2017 Jan;
24(2):270-275.
PMID: 28102047
Background And Purpose: A single, oral dose of 3 mg/day tacrolimus, approved for myasthenia gravis (MG) treatment in Japan, was shown to reduce steroid dose and anti-acetylcholine receptor (AChR) antibody...
7.
Lourenco A, Wellock N, Thomas R, Homer M, Bouchard H, Kanai T, et al.
Phys Med Biol
. 2016 Oct;
61(21):7623-7638.
PMID: 27740943
Water-equivalent plastics are frequently used in dosimetry for experimental simplicity. This work evaluates the water-equivalence of novel water-equivalent plastics specifically designed for light-ion beams, as well as commercially available plastics...
8.
Nagaya M, Matsunari H, Kanai T, Maehara M, Nakano K, Umeki I, et al.
Horm Metab Res
. 2016 Jun;
48(8):540-9.
PMID: 27341475
The present study aimed at establishing a new cryopreservation method for mouse pancreatic islets by vitrification using hollow fibers as a container. A unique feature of the hollow fiber vitrification...
9.
Uzawa A, Kawaguchi N, Himuro K, Kanai T, Kuwabara S
Clin Exp Immunol
. 2014 Mar;
176(2):232-7.
PMID: 24666229
Myasthenia gravis (MG) is an autoimmune-mediated inflammatory disease of the neuromuscular junction. Previous studies of animal MG models have suggested important roles of cytokines in MG pathogenesis, but adequate studies...
10.
Souda H, Yamada S, Kanai T, Takeshita E, Muramatsu M, Kitagawa A, et al.
Rev Sci Instrum
. 2014 Mar;
85(2):02A934.
PMID: 24593513
An ECR ion source of Gunma University Heavy Ion Medical Center, so-called KeiGM [M. Muramatsu, A. Kitagawa, Y. Sakamoto, S. Sato, Y. Sato, H. Ogawa, S. Yamada, H. Ogawa, Y....